Sort by
Refine Your Search
-
: Maintenance of IND/CTAs and/or NDAs/MAAs Regulatory strategy Regulatory intelligence Agency meeting management and correspondence Global/regional labeling Regulatory operations The fellow will have the
-
Therapeutics We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet needs. We involve key thought leaders, physicians
-
the Institute for Mechanobiology (IfM) in Boston, MA (see https://mechanobiology.northeastern.edu/our-faculty for list of the IfM core faculty). This position has an initial 2-year appointment, renewable
-
, a7nAChR, a9* nAChR, GIRK1/2, GIRK1/4etc.). Key initial responsibilities will include biochemical and ADME/PK studies and data analysis, SAR hypothesis generation, empirical and structure-based target design
-
challenges and opportunities made possible by human-machine collaboration. The Institute provides a framework to design, implement, and scale AI-driven technologies in ways that make a true difference to
-
Affairs fellowship, based in Boston, Massachusetts. About Zevra Therapeutics We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with
-
Affairs fellowship, based in Boston, Massachusetts. About Zevra Therapeutics We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with
-
; and Associate Director of the Institute for Health Equity and Social Justice Research (IHESJR). We are seeking an early career scientist who is committed to strengths-based research that advances health
-
culture that fosters collaboration, growth, and innovative thinking - a place where you can make an impact and help change the standard of care in non-opioid pain management. Be part of our movement, let’s
-
to tackle some of the most challenging problems in drug discovery and development. Today, we're a driving force behind innovative therapies that make a lasting difference to millions of patients around the